Evidence map›Paper›PMID 23885763›Full record

ArticleBlood pressure2014

Hypertension-associated hospitalizations and costs in the United States, 1979-2006.

Guijing Wang, Jing Fang, Carma Ayala

Registry-linked trialAbstract read
In one paragraph

Article in Blood pressure, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03281772 (Technology Assisted Management of Uncontrolled Hypertension), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03281772 terminatednot on this mapstarted 2017, after this paper: background citation

Technology Assisted Management of Uncontrolled Hypertension (TEAM-HTN): a Pilot Study

TypeobservationalSponsorMadigan Army Medical CenterRan2017 to 2018Enrolled70ConditionsUncontrolled HypertensionArmsClinical Decision Software - provider portal, Clinical Decision Software - patient portal
3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Baroreflex activation therapy reduces frequency and duration of hypertension-related hospitalizations in patients with resistant hypertension.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2020
    Article
  9. The global epidemiology of hypertension.Nature reviews. Nephrology · 2020
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Guijing WangDivision for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC) , Atlanta, GA 30341 , USA.
Jing Fang
Carma Ayala

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

BACKGROUND AND

objectiveIn the USA, the prevalence of hypertension has been high and increasing in recent decades. Even so, little is known about the changes over time in hospitalizations and the economic burden associated with this epidemic. We examined hypertension-associated hospitalizations and costs from 1979 to 2006.

methodsUsing the National Hospital Discharge Survey and the costs of community hospitals in the USA, we analyzed the changes in hypertension-associated hospitalizations and costs over time. We included those hospitalizations with a primary or secondary diagnosis of hypertension among patients aged 25 years and above. We examined changes in costs by adjusting them into year 2008 dollars. The costs included hospital expenses of payroll, employee benefits, professional fees and supplies.

resultsFrom 1979-1982 to 2003-2006, the proportion of hospitalizations that were associated with hypertension (primary or secondary diagnosis) increased from 1.9% to 5.4%. Among all hypertension-associated hospitalizations, the proportion with a secondary diagnosis of hypertension increased from 81.8% to 95.1%. In 2008 dollars, annual costs for hypertension-related hospitalizations increased from US$40 billion (5.1% of total hospital costs) during 1979-1982 to US$113 billion (15.1% of total hospital costs) during 2003-2006.

conclusionsBoth the proportions of hospitalizations that were associated with hypertension and the adjusted annual costs of such hospitalizations nearly tripled over the past 28 years. The increases were in substantial measure due to the greatly increasing proportion of hospitalizations in which hypertension was listed as a secondary diagnosis. Interventions for the management of hypertension as a secondary diagnosis might be potentially cost-effective.

Indexed as

AdultAgedAged, 80 and overFemaleHealth Care CostsHospitalizationHumansHypertensionMaleMiddle AgedPrevalenceUnited States

Identifiers

PMID23885763
PMCPMC4544734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.